Movement Alert｜Medline Inc. falls 3.09% in Regular Trading, shares pull back after UBS raised its target price

Market Focus

Yesterday

On November 6, Medline Inc. fell 3.09% in Regular Trading, trading at $39.15 per share, with turnover of $23.2741 million.

The clearest catalyst in publicly available coverage is a post-earnings pullback even after UBS raised its target price to $49 from $43 and maintained a Buy rating.

Recent background remains supportive: Medline Inc. previously reported fiscal third-quarter adjusted EPS of $0.44, above the $0.35 consensus, while revenue reached $7.856 billion, topping the expected $7.723 billion and rising from $7.12 billion a year earlier. After the earnings-driven rally, the latest session's weakness appears tied to profit-taking despite the positive analyst target revision.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1150224987"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150224987\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150224987?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-11-06 22:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150224987","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Medline Inc. falls 3.09% in Regular Trading, shares pull back after UBS raised its target price","media":"Market Focus","content":"<p><p>On November 6, Medline Inc. fell 3.09% in Regular Trading, trading at $39.15 per share, with turnover of $23.2741 million.</p><p>The clearest catalyst in publicly available coverage is a post-earnings pullback even after UBS raised its target price to $49 from $43 and maintained a Buy rating.</p><p>Recent background remains supportive: Medline Inc. previously reported fiscal third-quarter adjusted EPS of $0.44, above the $0.35 consensus, while revenue reached $7.856 billion, topping the expected $7.723 billion and rising from $7.12 billion a year earlier. After the earnings-driven rally, the latest session's weakness appears tied to profit-taking despite the positive analyst target revision.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Medline Inc. falls 3.09% in Regular Trading, shares pull back after UBS raised its target price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Medline Inc. falls 3.09% in Regular Trading, shares pull back after UBS raised its target price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-11-06 22:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On November 6, Medline Inc. fell 3.09% in Regular Trading, trading at $39.15 per share, with turnover of $23.2741 million.</p><p>The clearest catalyst in publicly available coverage is a post-earnings pullback even after UBS raised its target price to $49 from $43 and maintained a Buy rating.</p><p>Recent background remains supportive: Medline Inc. previously reported fiscal third-quarter adjusted EPS of $0.44, above the $0.35 consensus, while revenue reached $7.856 billion, topping the expected $7.723 billion and rising from $7.12 billion a year earlier. After the earnings-driven rally, the latest session's weakness appears tied to profit-taking despite the positive analyst target revision.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDLN","symbol_name":"Medline Inc","start_time":0,"source_url":"","article_id":"1150224987","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150224987","pubTimestamp":1793976746,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On November 6, Medline Inc. fell 3.09% in Regular Trading, trading at $39.15 per share, with turnover of $23.2741 million.The clearest catalyst in publicly available coverage is a post-earnings...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDLN":"Medline Inc"},"translate_title":"走势警报|Medline Inc. 常规交易中下跌 3.09%，瑞银上调目标价后股价回落","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDLN":1},"content_text":"On November 6, Medline Inc. fell 3.09% in Regular Trading, trading at $39.15 per share, with turnover of $23.2741 million.The clearest catalyst in publicly available coverage is a post-earnings pullback even after UBS raised its target price to $49 from $43 and maintained a Buy rating.Recent background remains supportive: Medline Inc. previously reported fiscal third-quarter adjusted EPS of $0.44, above the $0.35 consensus, while revenue reached $7.856 billion, topping the expected $7.723 billion and rising from $7.12 billion a year earlier. After the earnings-driven rally, the latest session's weakness appears tied to profit-taking despite the positive analyst target revision.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}